Background: Animal models in pain research have suggested that inclusion of both evoked and nonevoked behavioral measures is needed to better reflect the human pain experience. Individuals with chronic pain are known to experience spontaneous pain, in addition to pain after exposure to an external stimulus. Recently, the dynamic weight bearing (DWB) apparatus was developed to assess for nonevoked hyperalgesia by capturing weight bearing and surface distribution in the paws of mice after acute inflammation.
P ain is a critically important public health concern affecting more than 100 million adults in the United States and costing $635 billion annually in the treatment cost, lost productivity, and disability cost (Institute of Medicine [IOM], 2011). The IOM has deemed chronic pain as a national challenge requiring the participation of government agencies, healthcare providers, healthcare professional associations, educators, and public and private funders of healthcare to improve the prevention, assessment, and management of the various types of pain. Patients with chronic pain conditions report disruptions in mental health, performance of daily activities, and sexual function as well as an overall reduction in quality of life (Fine, 2011; IOM, 2011; Kalaydjian & Merikangas, 2008) . Despite the debilitating physical and substantial economic burden associated with chronic pain, the biological underpinnings of many pain conditions have yet to be elucidated, and effective treatment remains a challenge. Animalbehavioral pain models in preclinical research have played an integral role in the advancement of knowledge regarding mechanistic insight into pain and the development and identification of novel therapeutic targets for chronic pain conditions (Berge, 2011; Gregory et al., 2013; Kissin, 2010) . Therefore, it is crucial to establish appropriate measurement techniques to facilitate preclinical evaluation of putative medicines and their potential effects (Tétreault, Dansereau, Doré-Savard, Beaudet, & Sarret, 2011) . assessing pain utilizing laboratory animal models of pain are often employed. Many of these methods involve observations of animals for behavioral responses that infer nociception and hyperalgesia. Nociceptive responses are behavioral reactions indicative of the pain triggered by stimulation of peripheral nerve fibers (e.g., nociceptors) that respond only to stimuli approaching or exceeding harmful intensity (Loeser & Treede, 2008) . Hyperalgesia is an increase in pain sensitivity and is inferred from a decrease and/or an increase in the threshold response. Examples of conventional measurements for thermal and mechanical pain include the hot/cold plate and von Frey filament tests (see Table, Supplemental Digital Content 1, http://links.lww.com/NRES/A136). These tests investigate evoked, reflexive nociceptive responses (i.e., paw withdrawal, paw licking) to experimenter-introduced external stimuli (i.e., temperature, nylon filament). Although these tests may adequately assess pain after a noxious stimulus, they do not address the spontaneous or continuous pain that occurs in pain conditions. Recent reviews of animal pain models have suggested that inclusion of both evoked and nonevoked behavioral measures is needed to improve animal models of pain and better reflect the human pain experience (Berge, 2011; Gregory et al., 2013; Mogil, 2009; Whittaker & Howarth, 2014) .
Weight Bearing in Clinical and Preclinical Models of Pain
Weight-bearing evaluation has been used to monitor disease progress and treatment effectiveness in clinical inflammatory pain conditions, including osteoarthritis and rheumatoid arthritis in humans (Neugebauer, Han, Adwanikar, Fu, & Ji, 2007; van der Leeden et al., 2008; Wickman, Pinzur, Kadanoff, & Juknelis, 2004) . With the aim of making rodent pain model experimental findings more translatable to the human pain conditions, instruments assessing weight bearing have been increasingly utilized (Doré-Savard et al., 2010; Ferland, Laverty, Beaudry, & Vachon, 2011; Möller, Berge, & Hamers, 2008; Robinson, Sargent, & Hatcher, 2012; Tétreault et al., 2011) . The dynamic weight bearing (DWB) device is based on pressure sensors and an open recording area for mice to move without restraint and is capable of measuring multiple weightbearing parameters. The DWB test has shown alterations in weight bearing in inflammatory pain models in both mice and rats (Doré-Savard et al., 2010; Lolignier et al., 2011; Robinson et al., 2012; Tétreault et al., 2011) . As stated earlier, studies composed of evoked and nonevoked measures may increase their clinical relevance. None of these prior studies have incorporated a well-established assay for thermal hyperalgesia in addition to weight bearing-all within the same group of mice. Therefore, the aim of this study is to evaluate the DWB test as a measure of nonevoked pain, while also incorporating a test for evoked thermal pain sensitivity in the complete Freund's adjuvant (CFA) mouse model of inflammatory pain.
MATERIALS AND METHODS

Animals
This study followed the International Association for the Study of Pain guidelines for investigations of pain in animals (Zimmerman, 1986) . The study received approval from the institutional animal care and use committee of the University of Maryland School of Medicine (Protocol #0613006). Forty-five adult male C57BL/6J mice at 9 weeks (21-30 g; Jackson Laboratory, Bar Harbor, ME) were used in this study. Mice were housed on a 12:12 hour light-dark cycle with food and water available ad libitum.
Research Design
This randomized case control study used the CFA-induced persistent inflammatory pain model (Möller et al., 2008; Parvathy & Masocha, 2013; Robinson et al., 2012) . The treatment group received an injection of CFA in the left hind paw, the vehicle control group received an injection of saline in the left hind paw, and the naive control group received no injection. The right hind paw was used as an internal control for the DWB test. Forty-five mice were randomized into the experimental, vehicle, and naive control groups, resulting in 15 mice per group. Four measurement tools were employed in this study:
• the calipers and;
• the plethysmometer was used to verify that CFA injection produced hind paw inflammation; • the hot-plate test confirmed the development of hyperalgesia; and • the DWB test assessed weight-bearing distribution.
Baseline assessments were performed on all measurements 24 hours before treatment. Posttreatment measurements were taken at 3 hours and 1, 3, and 7 days ( Figure 1 ). Measurements were always conducted in the following order: DWB, caliper, and plethysmometer. To minimize stress in the mice, the hotplate test was completed at baseline, 1 day, and 7 days after the plethysmometer. All mice were tested on all measures individually and sequentially (i.e., Mouse 1 from the naive control group followed by Mouse 1 from the vehicle control group, followed by Mouse 1 from the experimental group, followed by Mouse 2 from the naive control group, etc.). This experimental order was maintained throughout the study for all measurement tools. 
Inflammatory Pain Model
Induction of Inflammation To induce peripheral inflammation in the experimental group, mice received a subcutaneous injection of 20 μl of CFA into the plantar surface of the left hind paw. CFA is an inflammatory agent consisting of 1 mg Mycobacterium tuberculosis (heat killed and dried), 0.85 ml of paraffin oil, and 0.15 ml of mannide monooleate. CFA causes an augmented immune response producing localized erythema and edema (Sigma-Aldrich, 2013) . CFA has been shown to exhibit an inflammatory effect 3 hours after injection and may persist for up to 4 weeks (Renn & Dorsey, 2011) . The vehicle control group received an injection of 20 μl of saline in the left hind paw; the naive control group received no injection.
Verification of Inflammation
To verify peripheral inflammation, each mouse hind paw was measured with a caliper and a plethysmometer. The caliper was used to measure paw thickness in millimeters of the dorsal-plantar axis at the metatarsal level (Morris, 2003) . Each paw was measured three times, and an average was calculated. The plethysmometer was used to measure paw volume by calculating fluid volume displacement in a measurement chamber (Morris, 2003) . The plethysmometer consists of two interconnected, clear acrylic tubes filled with a conductive solution, and it is connected to a decoder that digitally displays the volume displaced (Harvard Apparatus, Holliston, Massachusetts). One at a time, each hind paw was lowered up to the lateral malleolus into the smaller acrylic tube-the larger tube reflected the water volume displaced, and the decoder displayed the result in milliliters. Each hind paw was measured twice, and an average was calculated.
Behavioral Testing
Hot-Plate Test Using an incremental hot/cold plate (IITC, Woodland Hills, CA), the thermal nocifensive response was measured by calculating the temperature at which a mouse displays a positive stimulus-response behavior, which is defined for this study as licking either hind paw. Each mouse was placed individually on a 30°C (nonnoxious temperature) hot plate inside a clear acrylic cylinder. The temperature was increased at a ramp rate of 10°C per minute. An observer ended the test once the mouse licked either hind paw or the hot plate reached the machine-designated safety cutoff temperature of 50°C. The temperature was measured to the nearest 0.1°. Each mouse was measured twice, and an average was calculated. The presence of thermal hyperalgesia was defined as a decrease in the temperature that elicits paw licking from the baseline preinflammation measurement.
Dynamic Weight Bearing
The DWB test (Bioseb, Pinellas Park, FL) calculates multiple parameters in freely moving mice, including weight bearing for each paw (gram and percentage of total animal weight), weight for grouped front and rear paws (gram and percentage of total animal weight), left-right and front-rear weight ratio, surface for each paw, surface for grouped front and rear paws, and variability for each parameter. Parameters are given for the duration of different postures (i.e., four paws and rearing) and total time spent on each paw over the whole experiment. The parameters utilized in this study were weight on each paw in grams, surface of each paw in square millimeters, and front-rear weight ratio. Each mouse was individually placed in an 11-cm-wide Â 11-cm-long Â 22-cm-high Plexiglas enclosure with a floor sensor containing 1,936 pressure transducers. The mouse was allowed to move freely for 5 minutes while a camera recorded each movement. The video recordings and pressure data relayed from the floor sensors were transmitted to a computer and stored for analysis. After the recordings, an observer validated the data by comparing the live recordings with a scaled map of activated sensors. The observer verified the accuracy in placement of rear and front right paws, rear and front left paws, and other areas such as the tail. The DWB software then determined surface and pressure parameters automatically. Each mouse was measured once at each time point.
Statistical Analysis
Statistical analyses were conducted with Statistical Package for the Social Sciences (SPSS) 21.0, and graphs were created with GraphPad Prism version 6.0d. Values were expressed as mean ± standard error of the mean. Comparison of mouse weight in grams was analyzed with a one-way analysis of variance (ANOVA). Comparisons between groups and across time points were analyzed by two-way repeated measures ANOVA. Greenhouse-Geisser estimates were utilized when there was a violation of sphericity. To determine which groups and time points differed, Bonferonni post hoc tests were conducted for a statistically significant ANOVA with nominal p values of .05 for caliper, plethysmometer, and hot-plate test. To assess withingroup differences in DWB ipsilateral and contralateral weight bearing and surface distribution in the hind paws, dependent samples t tests were conducted for each group separately. Means for all comparisons are available in Table, 
RESULTS
Inflammatory Response
A two-way repeated measures ANOVA showed that there was a significant main effect for time (F(3, 42) = 94.09, p < .001), treatment group (F(2, 42) = 261.10, p < .001), and interaction between time and treatment (F(6, 42) = 77.77, p < .001) for the caliper measurements (i.e., paw thickness). There was a similar significant main effect for time (F(3, 42) = 32.88, p < .001), treatment group (F(2, 42) = 17.96, p < .001), and interaction between time and treatment (F(6, 42) = 26.55, p < .001) for the plethysmometer measurements (i.e., paw volume). There was no significant difference between the groups at baseline for either paw thickness or paw volume. CFA-treated mice showed a higher mean paw thickness and volume displacement compared with the vehicle (p < .001) and naive (p < .001) control groups in the ipsilateral paw, beginning at 3 hours after CFA injection and continuing for the experimental duration (p < .001; Figure 2 ). Analysis of simple effects for time showed that paw thickness and paw volume were significantly greater than baseline in CFA-treated mice at 3 hours, 1 day, and 3 and 7 days (p < .01). Vehicle and naive groups showed no difference in mean paw thickness and volume displacement compared with each other through the duration of the experiment. When percent change was calculated for the caliper measurement of CFA-treated mice, ipsilateral paw thickness had increased by 58% at 3 hours and 75% on Day 1 from baseline. The plethysmometer recorded an average of 0.04-to 0.05-ml increase in volume displacement in the ipsilateral paw of CFA-treated mice compared with those of the vehicle and naive control groups from baseline. The results indicated that the CFA was successful in inducing inflammation as soon as 3 hours and up to 7 days after injection. After paw inflammation, the mice continued to eat, drink, groom, and explore their environment normally.
Nocifensive Behavior
Hot-Plate Test There was a significant main effect for time and Time Â Treatment group interaction for the hot-plate test. There was no significant difference between the groups at baseline. Thermal hyperalgesia as measured by the hot-plate test was apparent in the CFA-treated mice by Day 3. There was a statistical significance in thermal hyperalgesia as compared with baseline by Day 7 in CFA-treated mice (p = .001; Figure 3) . The CFA-treated mice posted an 8.2% decrease in response temperature by Day 7 compared with the temperature recorded at baseline; the percent decrease in the naive group was 3.2% and, in the saline group, was 1.3% ( Figure 3B ). By Day 7, CFA-treated mice recorded a positive response at 43.5°, the naive group was 2°higher (45.5°C), and the saline-treated mice recorded the highest temperature response (46.6°C; Figure 3A ). CFA-treated mice responded at a significantly lower temperature than the saline group at Day 7 (p < .05). The naive and saline groups did not show any significant difference between each other or across time. Overall, these results showed that CFA-treated mice licked their hind paw at lower temperatures compared with salinetreated mice indicating that CFA was successful in producing thermal hyperalgesia by Day 7.
Dynamic Weight Bearing Weight bearing as measured by DWB was noted as a reduction in the ipsilateral paw load compared with the contralateral paw load at Day 1 (p < .001), Day 3 (p = .006), and Day 7 (p = .002) for CFA-treated mice, but no difference in paw load was found in the saline-treated or naive mice (Figure 4) . On Day 1, CFA-treated mice recorded a 7.3% drop in ipsilateral paw load, whereas the contralateral paw load increased by 17.8% from baseline. Differences were also found in the ipsilateral paw surface area compared with the contralateral paw surface area at Day 1 (p < .001), Day 3 (p = .004), and Day 7 (p = .009) for CFA-treated mice but not for salinetreated or naive mice (Figure 4) . Although the CFA-treated mice showed a higher proportion of front-rear ratio in weight bearing compared with the saline-treated and naive mice, this was not statistically significant. The results of the paw thickness measurements and the behavioral response to thermal stimulation confirmed the presence of inflammation with hyperalgesia; this indicates that the differences between the CFA group and the vehicle and naive groups in the DWB test are likely because of the presence of inflammatory hyperalgesia or allodynia. Taken together, the findings of this study suggest that the DWB instrument is a valid instrument to identify nocifensive behaviors that are not stimulus evoked.
DISCUSSION
To increase the clinical translation of this study, mice were evaluated in both evoked (i.e., hot plate) and nonevoked (i.e., DWB) pain conditions. The CFA model of inflammatory pain has been used in previous research to model inflammatory conditions such as rheumatoid arthritis, tendonitis, and general inflammatory pain (Cobos et al., 2012; Gregory et al., 2013; Tétreault et al., 2011) . CFA-treated mice evidenced greater thermal hyperalgesia in comparison with vehicle control and naive mice when exposed to a heat stimulus. CFA-treated mice also showed alterations in weight bearing, including reduced paw load and surface distribution for the affected paw. These findings support the use of DWB test as a tool for measuring nonevoked inflammatory hyperalgesia in the mouse model. This approach is highly translatable as it measures continuous and/or spontaneous pain often associated with clinical inflammatory pain conditions.
Overall, the results are consistent with other studies that have utilized the DWB test to assess alterations in weight bearing after induction of inflammation (Cobos et al., 2012; Doré-Savard et al., 2010; Lolignier et al., 2011; Robinson et al., 2012; Tétreault et al., 2011) . This study contributes new information to this literature as none of these prior studies employed a measure of evoked hyperalgesia (i.e., thermal hyperalgesia) in addition to weight bearing. To further strengthen the validity of the findings, all mice were subjected to all experimental procedures in a standardized order, and repeated measurements were taken for methods involving experimental subjectivity. Inflammation was verified at each data collection point by both bilateral paw thickness and paw volume displacement. Weight bearing was always assessed before inflammation verification and the hot-plate test to minimize the possible influence of animal handling required for these assessments and exposure to a noxious thermal stimulus on weight-bearing behavior.
Other tests used to assess weight-bearing and nociceptive behavior in preclinical pain models include the CatWalk gait analysis system and the Incapacitance test (Möller et al., 2008; Parvathy & Masocha, 2013) . The CatWalk gait analysis system (Noldus Information Technology, Wageningen, The Netherlands) consists of an enclosed walkway with a glass plate floor in which the mouse is to walk from one end to the other. Light is illuminated where the mouse paws make contact with the glass plate resulting in an image of the paw print to estimate weight bearing. The Incapacitance test involves positioning the animal in a chamber with their hind paws on two separate weightbearing sensors. Both the CatWalk and Incapacitance tests involve confinement of the animal and do not allow calculation of weight-bearing parameters that occur during typical rodent actions, such as rearing and exploring their environment. Assessment of weight bearing in freely moving mice permitted by the DWB test may be more clinically relevant as it analyzes continuous weight-bearing behavior as a method to measure spontaneous, nonevoked pain.
There is minimal literature reporting the use of the DWB apparatus as a measure of nonevoked inflammatory hyperalgesia in mice (Cobos et al., 2012; Robinison et al., 2012) . This study further reinforces its relevance to study in mice. The use of the DWB test in mice offers possibilities for future research evaluating novel analgesics in inflammatory models as well as other mouse models of pain, including surgical, neuropathic, and cancer. Furthermore, with the increase of transgenic mouse models, valid behavioral methods for use in mice are required.
Limitations
There are a few limitations in this study. Experimenter blinding was not employed in this study. Although blinding would have been ideal, it was not possible as the CFA-injected paws become markedly red and edematous within 3 hours of injection. Although several minutes longer than static weight-bearing measurement, the observation period in DWB is still quite brief at 5 minutes. Moreover, although the DWB test enclosure allows freedom of movement, there is likely to be some confinement and displacement-associated stress. For the hot-plate test, paw licking was the solitary indication of thermal pain. Although this increased consistency, other studies have utilized any sign that could be indicative of thermal pain (paw licking, flinching, jump response; Abu-Ghefreh & Masocha, 2010). Finally, there was no statistical control for the multiple number of post hoc comparisons conducted, thus increasing the risk of a type I error.
Conclusions
Individuals with inflammatory pain conditions (e.g., rheumatoid and osteoarthritis) experience spontaneous pain as well as pain in response to an external stimulus; therefore, it is imperative that preclinical animal models and associated behavioral assessment methods strive to closely reflect the clinical pain experience. The current findings suggest that the DWB test may be a valuable instrument for future research investigating pain conditions using a mouse model.
